Dr. Davoud Mohtat, MD

Dr. Davoud Mohtat, MD

Dr. Davoud Mohtat, MD

Languages: English
Fax: (877) 680-5502

Contact this Provider:

  • Pediatric Nephrology
Conditions I Treat
  • chronic kidney disease (ckd)
  • diabetic nephropathy
  • focal segmental glomerulosclerosis
  • glomerulonephritis
  • hematuria
  • Show All
  • Fellowship Program: Montefiore Dental (2010)
  • Internship/Residency: SUNY Downstate Medical Center (2007)
  • Medical School: Uludag University (1998)
  • Board Certification: American Board of Pediatrics, Pediatric Nephrology
  • Board Certification: American Board of Pediatrics, Pediatrics


Transcriptome analysis of human diabetic kidney disease.

Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, Susztak K.Diabetes. 2011 Sep;60(9):2354-69. doi: 10.2337/db10-1181. Epub 2011 Jul 13.PMID: 21752957 Free PMC article.

Fine tuning gene expression: the epigenome.

Mohtat D, Susztak K.Semin Nephrol. 2010 Sep;30(5):468-76. doi: 10.1016/j.semnephrol.2010.07.004.PMID: 21044758 Free PMC article. Review.

Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development.

Ko YA, Mohtat D, Suzuki M, Park AS, Izquierdo MC, Han SY, Kang HM, Si H, Hostetter T, Pullman JM, Fazzari M, Verma A, Zheng D, Greally JM, Susztak K.Genome Biol. 2013;14(10):R108. doi: 10.1186/gb-2013-14-10-r108.PMID: 24098934 Free PMC article.

Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.

Hu CY, Mohtat D, Yu Y, Ko YA, Shenoy N, Bhattacharya S, Izquierdo MC, Park AS, Giricz O, Vallumsetla N, Gundabolu K, Ware K, Bhagat TD, Suzuki M, Pullman J, Liu XS, Greally JM, Susztak K, Verma A.Clin Cancer Res. 2014 Aug 15;20(16):4349-60. doi: 10.1158/1078-0432.CCR-14-0494. Epub 2014 Jun 10.PMID: 24916699 Free PMC article.

Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease.

Mohtat D, Thomas R, Du Z, Boakye Y, Moulton T, Driscoll C, Woroniecki R.Pediatr Nephrol. 2011 Feb;26(2):275-80. doi: 10.1007/s00467-010-1677-9. Epub 2010 Nov 25.PMID: 21107986

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.

Hauser RA, Lew MF, Hurtig HI, Ondo WG, Wojcieszek J, Fitzer-Attas CJ; TEMPO Open-label Study Group.Mov Disord. 2009 Mar 15;24(4):564-73. doi: 10.1002/mds.22402.PMID: 19086083 Clinical Trial.

    MedStar Health Providers participate with a wide range of health insurance products. We accept self-pay patients and the insurances plans listed below. This list is not comprehensive, it is updated periodically and is subject to change. If you do not see your health insurance plan or product listed, or if you have any questions regarding MedStar Health’s participation with your health plan, please contact your health plan to verify participation with our providers.

    Since the MedStar Health providers span the District of Columbia, Maryland and Virginia regions, our participation with DC, Maryland and Virginia Medical Assistance programs varies by provider group. Please contact your MedStar Physician’s Office to assist with verifying Medical Assistance participation. If you are enrolled in a Medicaid Managed Care Organization, please contact your Medicaid health plan to verify participation.
Practice Locations
  • 4200 Wisconsin Avenue Northwest
    Suite 400
    Washington, DC 20016
    View Map

    Phone: 202-243-3400
    Fax: 202-243-3434

Member of Medical Staff
  • MedStar Georgetown University Hospital